AATC vs. MASS, FEIM, SEER, RPID, KEQU, NAUT, ODYS, INTT, AKYA, and OWLT
Should you be buying Autoscope Technologies stock or one of its competitors? The main competitors of Autoscope Technologies include 908 Devices (MASS), Frequency Electronics (FEIM), Seer (SEER), Rapid Micro Biosystems (RPID), Kewaunee Scientific (KEQU), Nautilus Biotechnology (NAUT), Odysight.Ai (ODYS), inTEST (INTT), Akoya Biosciences (AKYA), and Owlet (OWLT). These companies are all part of the "measuring and control equipment" industry.
Autoscope Technologies vs.
Autoscope Technologies (NASDAQ:AATC) and 908 Devices (NASDAQ:MASS) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.
In the previous week, 908 Devices had 5 more articles in the media than Autoscope Technologies. MarketBeat recorded 7 mentions for 908 Devices and 2 mentions for Autoscope Technologies. 908 Devices' average media sentiment score of 0.54 beat Autoscope Technologies' score of 0.33 indicating that 908 Devices is being referred to more favorably in the news media.
Autoscope Technologies has higher earnings, but lower revenue than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Autoscope Technologies, indicating that it is currently the more affordable of the two stocks.
Autoscope Technologies has a net margin of 37.59% compared to 908 Devices' net margin of -109.11%. Autoscope Technologies' return on equity of 27.06% beat 908 Devices' return on equity.
Autoscope Technologies has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500.
88.1% of 908 Devices shares are held by institutional investors. 21.6% of Autoscope Technologies shares are held by company insiders. Comparatively, 27.7% of 908 Devices shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
908 Devices received 19 more outperform votes than Autoscope Technologies when rated by MarketBeat users. Likewise, 48.72% of users gave 908 Devices an outperform vote while only 0.00% of users gave Autoscope Technologies an outperform vote.
908 Devices has a consensus price target of $5.33, indicating a potential downside of 0.50%. Given 908 Devices' stronger consensus rating and higher probable upside, analysts clearly believe 908 Devices is more favorable than Autoscope Technologies.
Summary
908 Devices beats Autoscope Technologies on 10 of the 18 factors compared between the two stocks.
Get Autoscope Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AATC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Autoscope Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:AATC) was last updated on 5/1/2025 by MarketBeat.com Staff